期刊文献+

利培酮或传统抗精神病药长期治疗对精神分裂症QTc间期影响 被引量:13

Impact of long-term treatment with risperidone or typical antipsychotics on QTc in schizophrenic patients
原文传递
导出
摘要 目的:探讨利培酮与传统抗精神病药长期治疗的精神分裂症患者心电图校正QT间期(corrected QT interval,QTc)差异及相关因素。方法:将服用利培酮(n=44)或传统抗精神病药(n=44)12个月以上的精神分裂症患者纳入研究,检测心肌酶等生化指标及心电图,按Bazett's公式计算QTc间期,以QTc>440 ms作为QTc间期延长标准。用直线相关分析和直线回归分析法分析QTc间期与其他因素之间的关系。结果:利培酮组QTc间期(398.73±23.76)ms较传统抗精神病药物组(413.82±23.21)ms短(P<0.05),利培酮组QTc间期延长发生率(2.27%,1例)低于传统抗精神病药物组(18.18%,8例)(P<0.05)。利培酮组性别、剂量与QTc间期相关(P<0.05);传统抗精神病药物组性别、年龄与QTc间期相关(P<0.05)。结论:利培酮对QTc间期影响较传统抗精神病药小,女性是QTc间期延长危险因素。 Objective: To compare the effects of long-term treatment with risperidone or typical antlpsy- chotics on QTc interval and the relative impacting factors. Methods: Schizophrenic patients, who received maintenance treatment with risperidone (n = 44) or typical antipsychotics ( n = 44) beyond 12 months, were enrolled. QT intervals, myocardial enzymes and other biochemical indexes were measured ; QTc intervals were calculated accord- ing Bazett's formula, the diagnostic criterion of QTc prolongation was QTc 〉 440 ms. The relationship between QTc intervals and the relative factors were analyzed by linear correlation and linear regression. Results: QTc intervals (398.73 ±23.76) ms in risperidone group were shorter than those (413.82± 23.21 ) ms in typical antipsychotic group (P 〈 0.05 ), the QTc prolongation prevalence rate (1/44, 2.27% ) in risperidone group was lower than that (8/44, 18. 18% ) in typical antipsychotic group. QTc intervals were correlated with gender and dosage ( P 〈 0.05) in risperidone group ; while they were correlated with gender and age (P 〈 0.05) in typical antipsychotic group. Conclusion: Risperidone has less effect on QTc intervals than typical antipsychotics, and female is a risk factor of QTc intervals prolongation.
机构地区 北京回龙观医院
出处 《中国新药杂志》 CAS CSCD 北大核心 2014年第12期1418-1422,共5页 Chinese Journal of New Drugs
关键词 精神分裂症 利培酮 传统抗精神病药 QTC间期 schizophrenia risperidone typical antipsychotics QTc interval
  • 相关文献

参考文献13

二级参考文献94

  • 1谈艳,张少平,陈银娣.抗抑郁药和抗精神病药物所致QT间期延长和尖端扭转型室速[J].中国神经精神疾病杂志,2004,30(5). 被引量:12
  • 2Sanguinetti MC, Tristani - Firouzi M. hERG potassium channel andcardiac arrhythmia [ J ]. Nature, 2006 ; 440 : 463 - 469.
  • 3ICH Harmonized Tripartite Guideline El4. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for nonantiarrhythmie drugs [ EB/OL]. http://www, fda. gov/cder/ guidance/6922fnl, htm ,2005 - 05 - 12.
  • 4ICH Harmonized Tripartite Guideline S7B. Safety pharmacology assessment of the potential for delayed ventrieular repolarization ( QT Interval Prolongation ) by human pharmaceuticals [ EB/OL ]. http://www, fda. gov/cder/Guidance/6885fnl, htm ,2005-10.
  • 5Bloomfield DM, Kost JT, Ghosh K, et al. The effect of moxifloxacin on QTc and implications for the design of thorough QT studies [ J ]. Clin Pharmacol Ther, 2008 ; 84 : 475 - 480.
  • 6Malik M, Hnatkova K, Schmidt A, et al. Correction for QT/RR hysteresis in the assessment of druginduced QTc changes -cardiac safety of gadobutrol [ J ]. Ann Noninvasive Electrocardiol, 2009; 14 : 242 - 250.
  • 7ICH Harmonized Tripartite Guideline El4 Questions and Answers. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for nonantiarrhythmic drugs [ EB/OL ]. http :// www. fda. gov/cder/guidance/8466fnl, pdf,2008-06-04.
  • 8Van Noord C, Dorr M, Sturkenboom MC, et al. The association of serum testosterone levels and ventricular repolarization [ J ]. Eur J Epidemiol, 2010; 25:21 -28.
  • 9Jonsson MK, Vos MA, Duker G, et cd. Gender disparity in cardiac electrophysiology: implications for cardiac safety pharmacology[J]. Pharmacol Ther, 2010; 127 : 9 - 18.
  • 10Meng Z, Quan H, Fan L, et al. Use of the average baseline versus the timematched baseline in parallel group thorough QT/QTc studies [J]. J Biopharm Stat, 2010; 20:665-682.

共引文献86

同被引文献91

引证文献13

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部